Efficacy and Safety of Certolizumab Pegol in Japanese Patients with Generalized Pustular Psoriasis and Erythrodermic Psoriasis: 52-Week Results

INTRODUCTION: We report an exploratory analysis of the efficacy and safety of certolizumab pegol (CZP) in Japanese patients with generalized pustular psoriasis (GPP) and erythrodermic psoriasis (EP) (NCT03051217). METHODS: Patients ≥ 20 years with GPP or EP were randomized 1:1 to open-label CZP 400 ...

Descripción completa

Detalles Bibliográficos
Autores principales: Okubo, Yukari, Umezawa, Yoshinori, Sakurai, Shinya, Hoshii, Naoki, Nakagawa, Hidemi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209588/
https://www.ncbi.nlm.nih.gov/pubmed/35622315
http://dx.doi.org/10.1007/s13555-022-00741-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209588/
https://www.ncbi.nlm.nih.gov/pubmed/35622315
http://dx.doi.org/10.1007/s13555-022-00741-x

Ejemplares similares